Sodium cromolyn reduces expression of CTGF, ADAMTS1, and TIMP3 and modulates post-injury patellar tendon morphology

Journal of Orthopaedic Research

Volumn 29, Issue 5, 2011, Pages 678-683

  Sharma, Aishwariya ^a   Abraham, Thomas ^b   Sampaio, Arthur ^a   Cowan, Matthew ^a   Underhill, Michael ^a   Scott, Alexander ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

mast cells; patellar tendon injury

Indexed keywords

ADAMTS1 PROTEIN; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; CROMOGLYCATE DISODIUM; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION; MAST CELL; MOUSE; NONHUMAN; PATELLAR TENDON INJURY; PRIORITY JOURNAL; TENDON INJURY; TENDON RECONSTRUCTION;

ADAM PROTEINS; ANIMALS; CONNECTIVE TISSUE GROWTH FACTOR; CROMOLYN SODIUM; MAST CELLS; MICE; PATELLAR LIGAMENT; TISSUE INHIBITOR OF METALLOPROTEINASE-3; WOUND HEALING;

EID: 79952780840     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21291     Document Type: Article

References (33)

1. Svensson M, Kartus J, Christensen LR, et al. 2005. A long-term serial histological evaluation of the patellar tendon in humans after harvesting its central third. Knee Surg Sports Traumatol Arthrosc 13: 398-404. (Pubitemid 40991802)
2. Lui PP, Chan LS, Fu SC, et al. 2010. Expression of sensory neuropeptides in tendon is associated with failed healing and activity-related tendon pain in collagenase-induced tendon injury. Am J Sports Med 38: 757-764.
3. Stone D, Green C, Rao U, et al. 1999. Cytokine-induced tendinitis: a preliminary study in rabbits. J Orthop Res 17: 168-177. (Pubitemid 29190488)
4. Ackermann PW, Li J, Lundeberg T, et al. 2003. Neuronal plasticity in relation to nociception and healing of rat Achilles tendon. J Orthop Res 21: 432-441. (Pubitemid 36546809)
5. Lin TW, Cardenas L, Glaser DL, et al. 2006. Tendon healing in interleukin-4 and interleukin-6 knockout mice. J Biomech 39: 61-69. (Pubitemid 41585009)
6. Scott A, Lian O, Bahr R, et al. 2008. Increased mast cell numbers in human patellar tendinosis: correlation with symptom duration and vascular hyperplasia. Br J Sports Med 42: 753-757.
7. Kakar S, Khan U, McGrouther DA., 1998. Differential cellular response within the rabbit tendon unit following tendon injury. J Hand Surg [Br] 23: 627-632. (Pubitemid 28484698)
8. Shiota N, Nishikori Y, Kakizoe E, et al. 2010. Pathophysiological role of skin mast cells in wound healing after scald injury: study with mast cell-deficient W/W(V) mice. Int Arch Allergy Immunol 151: 80-88.
9. Dumont N, Lepage K, Cote CH, et al. 2007. Mast cells can modulate leukocyte accumulation and skeletal muscle function following hindlimb unloading. J Appl Physiol 103: 97-104. (Pubitemid 47092281)
10. Monument MJ, Hart DA, Befus AD, et al. The mast cell stabilizer ketotifen fumarate lessens contracture severity and myofibroblast hyperplasia: a study of a rabbit model of posttraumatic joint contractures. J Bone Joint Surg Am 92: 1468-1477.
11. Gallant-Behm CL, Hildebrand KA, Hart DA., 2008. The mast cell stabilizer ketotifen prevents development of excessive skin wound contraction and fibrosis in red Duroc pigs. Wound Repair Regen 16: 226-233. (Pubitemid 351342132)
12. Scott A, Sampaio A, Abraham T, et al. 2010. Scleraxis expression is coordinately regulated in a murine model of patellar tendon injury. J Orthop Res Published online in JOR, Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/jor. 21220 on Aug. 25.
13. Tsai M, Miyamoto M, Tam SY, et al. 1995. Detection of mouse mast cell-associated protease mRNA. Heparinase treatment greatly improves RT-PCR of tissues containing mast cell heparin. Am J Pathol 146: 335-343.
14. George J, Tsutsumi M., 2007. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther 14: 790-803. (Pubitemid 46706059)
15. Nakama LH, King KB, Abrahamsson S, et al. 2006. VEGF, VEGFR-1, and CTGF cell densities in tendon are increased with cyclical loading: an in vivo tendinopathy model. J Orthop Res 24: 393-400. (Pubitemid 43773000)
16. Chen CH, Cao Y, Wu YF, et al. 2008. Tendon healing in vivo: gene expression and production of multiple growth factors in early tendon healing period. J Hand Surg Am 33: 1834-1842.
17. Chen CH, Zhou YL, Wu YF, et al. 2009. Effectiveness of microRNA in down-regulation of TGF-beta gene expression in digital flexor tendons of chickens: in vitro and in vivo study. J Hand Surg Am 34: 1777-1784, e1.
18. Sandy JD, Westling J, Kenagy RD, et al. 2001. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 276: 13372-13378.
19. Corps AN, Jones GC, Harrall RL, et al. 2008. The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells. Matrix Biol 27: 393-401.
20. Jones GC, Corps AN, Pennington CJ, et al. 2006. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human Achilles tendon. Arthritis Rheum 54: 832-842.
21. Cross NA, Chandrasekharan S, Jokonya N, et al. 2005. The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFβ1 in prostate cells: relevance to the accumulation of versican. The Prostate 63: 269-275. (Pubitemid 40571061)
22. Mattila L, Airola K, Ahonen M, et al. 1998. Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol 110: 416-421. (Pubitemid 28158660)
23. Hart D, Frank C, Bray RC., 1995. Inflammatory processes in repetitive motion and overuse syndromes: potential role of neurogenic mechanisms in tendons and ligaments. In:, Fine LJ, editor. Repetitive motion disorders of the upper extremity. Rosemount: American Academy of Orthopaedic Surgeons; p 247-262.
24. Moyer KE, Saggers GC, Ehrlich HP., 2004. Mast cells promote fibroblast populated collagen lattice contraction through gap junction intercellular communication. Wound Repair Regen 12: 269-275. (Pubitemid 38880435)
25. Abe M, Kurosawa M, Ishikawa O, et al. 2000. Effect of mast cell-derived mediators and mast cell-related neutral proteases on human dermal fibroblast proliferation and type I collagen production. J Allergy Clin Immunol 106: S78-S84. (Pubitemid 30482839)
26. Iba Y, Shibata A, Kato M, et al. 2004. Possible involvement of mast cells in collagen remodeling in the late phase of cutaneous wound healing in mice. Int Immunopharmacol 4: 1873-1880. (Pubitemid 39504827)
27. Garbuzenko E, Nagler A, Pickholtz D, et al. 2002. Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin Exp Allergy 32: 237-246. (Pubitemid 34429602)
28. Miller HR, Pemberton AD., 2002. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105: 375-390. (Pubitemid 34429684)
29. Kischer CW, Bunce H III, Shetlah MR., 1978. Mast cell analyses in hypertrophic scars, hypertrophic scars treated with pressure and mature scars. J Invest Dermatol 70: 355-357. (Pubitemid 8369150)
30. Loiselle AE, Bragdon GA, Jacobson JA, et al. 2009. Remodeling of murine intrasynovial tendon adhesions following injury: MMP and neotendon gene expression. J Orthop Res 27: 833-840.
31. Nozaki M, Li Y, Zhu J, et al. 2008. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. Am J Sports Med 36: 2354-2362.
32. Nakamura N, Hart DA, Boorman RS, et al. 2000. Decorin antisense gene therapy improves functional healing of early rabbit ligament scar with enhanced collagen fibrillogenesis in vivo. J Orthop Res 18: 517-523.
33. Scott A, Bahr R., 2009. Neuropeptides in tendinopathy. Front Biosci 14: 2203-2211.